GFM
GF Fund Management Portfolio holdings
AUM
$4.97B
This Quarter Return
+7.58%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.62B
AUM Growth
–
Cap. Flow
+$4.62B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
48.03%
Holding
637
New
637
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
NVIDIA
NVDA
|
$390M |
| 2 |
Apple
AAPL
|
$374M |
| 3 |
Microsoft
MSFT
|
$322M |
| 4 |
Amazon
AMZN
|
$234M |
| 5 |
Meta Platforms (Facebook)
META
|
$194M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 45.53% |
| 2 | Consumer Discretionary | 17.29% |
| 3 | Communication Services | 14.35% |
| 4 | Healthcare | 6.6% |
| 5 | Consumer Staples | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Savara
SVRA
$643M
| $11.1K | ﹤0.01% |
+3,604
| New | +$11.1K |
|
527
Tourmaline Bio
TRML
$687M
| $10.9K | ﹤0.01% |
+538
| New | +$10.9K |
|
528
NiSource
NI
$19B
| $10.9K | ﹤0.01% |
+296
| New | +$10.9K |
|
|
WSR
529
Whitestone REIT
WSR
$672M
| $10.9K | ﹤0.01% |
+767
| New | +$10.9K |
|
530
PPL Corp
PPL
$26.6B
| $10.8K | ﹤0.01% |
+334
| New | +$10.8K |
|
531
Altimmune
ALT
$334M
| $10.8K | ﹤0.01% |
+1,493
| New | +$10.8K |
|
532
DTE Energy
DTE
$28.4B
| $10.7K | ﹤0.01% |
+89
| New | +$10.7K |
|
533
CMS Energy
CMS
$21.4B
| $10.7K | ﹤0.01% |
+161
| New | +$10.7K |
|
534
MindMed
MNMD
$702M
| $10.7K | ﹤0.01% |
+1,540
| New | +$10.7K |
|
535
Evergy
EVRG
$16.5B
| $10.7K | ﹤0.01% |
+174
| New | +$10.7K |
|
536
Ameren
AEE
$27.2B
| $10.7K | ﹤0.01% |
+120
| New | +$10.7K |
|
537
EyePoint Pharmaceuticals
EYPT
$966M
| $10.7K | ﹤0.01% |
+1,433
| New | +$10.7K |
|
538
Xeris Biopharma Holdings
XERS
$1.27B
| $10.6K | ﹤0.01% |
+3,130
| New | +$10.6K |
|
539
Astria Therapeutics
ATXS
$424M
| $10.6K | ﹤0.01% |
+1,185
| New | +$10.6K |
|
540
Pacific Biosciences
PACB
$381M
| $10.5K | ﹤0.01% |
+5,750
| New | +$10.5K |
|
541
CorMedix
CRMD
$926M
| $10.3K | ﹤0.01% |
+1,274
| New | +$10.3K |
|
|
VERV
542
DELISTED
Verve Therapeutics
VERV
| $10K | ﹤0.01% |
+1,778
| New | +$10K |
|
543
MeiraGTx Holdings
MGTX
$619M
| $9.99K | ﹤0.01% |
+1,641
| New | +$9.99K |
|
544
Terns Pharmaceuticals
TERN
$632M
| $9.88K | ﹤0.01% |
+1,783
| New | +$9.88K |
|
|
AUTL
545
Autolus Therapeutics
AUTL
$389M
| $9.85K | ﹤0.01% |
+4,193
| New | +$9.85K |
|
|
THRD
546
DELISTED
Third Harmonic Bio
THRD
| $9.73K | ﹤0.01% |
+946
| New | +$9.73K |
|
547
Theravance Biopharma
TBPH
$703M
| $9.72K | ﹤0.01% |
+1,033
| New | +$9.72K |
|
|
CHCT
548
Community Healthcare Trust
CHCT
$444M
| $9.72K | ﹤0.01% |
+506
| New | +$9.72K |
|
|
FPI
549
Farmland Partners
FPI
$473M
| $9.7K | ﹤0.01% |
+825
| New | +$9.7K |
|
550
Arcturus Therapeutics
ARCT
$485M
| $9.66K | ﹤0.01% |
+569
| New | +$9.66K |
|